Sponsors

Lead Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

Cystic Fibrosis Foundation

This proposal will be a cross sectional study of the current well-characterized PUSH cohort. Patients will receive an MRI at the time of their scheduled PUSH ultrasound. Ideally, the MRI will be performed the same day or a similar time point near liver ultrasound (+/-90 days, but Investigators will allow a larger window due to the slow progression of fibrosis). Blinded radiology review of imaging sequences will be performed by a local study radiologist with central review performed by the Imaging Core. Analysis by the Imaging Core will include calculation of the liver stiffness, liver and spleen volume, and hepatic and lipid content for all MRI studies.

Related studies

RECRUITINGNA

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis

Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

Trial snapshot

Condition

Locations shown

For caregivers